Keith Lamont Cummings
Chief Financial OfficerDr. Keith Lamont Cummings, M.D., MBA, serves as Chief Financial Officer at Pliant Therapeutics, Inc. since December 2018. Dr. Cummings is experienced in healthcare and financial services. Dr. Cummings joins Pliant from Citigroup Global Markets where he served as a Director in the Investment Banking Healthcare Group focusing on small- and mid-cap life sciences companies. While at Citigroup, Dr. Cummings specialized in public and private capital raising as well as M&A, and executed a broad range of transactions for many of the leading life sciences companies on the West Coast. Prior to Citigroup, he worked as an investment banker at Lehman Brothers and Barclays Investment Bank in New York from August 2009 to September 2014, where he served as a Vice President of Investment Banking. He holds a B.S. in Biochemistry from North Carolina State University, an MBA from Duke University’s Fuqua School of Business and an M.D. from Duke University School of Medicine.
Positions
- Company NamePliant Therapeutics, Inc.Stock CodePLRXPositionChief Financial OfficerColleagues
- BJBernard Jozef CouliePresident, CEO & Director
- HHHoyoung HuhIndependent Chairman & Lead Director
- MKMinnie KuoChief Operating Officer
- RDRik DerynckScientific Founder & Member of Scientific Advisory Board
- DSDean SheppardScientific Founder & Member of Scientific Advisory Board
- HCHal ChapmanScientific Founder & Member of Scientific Advisory Board
